Loading…
Tenax Therapeutics, Inc. is projected to rise to $23.04 by 2027, a +31% move from its current price of $17.55. TENX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $16.79 | $17.54 | $18.32 | -0.06% |
| Jul 15 | $16.48 | $17.53 | $18.64 | -0.13% |
| Jul 16 | $16.24 | $17.52 | $18.89 | -0.19% |
| Jul 17 | $16.05 | $17.51 | $19.10 | -0.25% |
| Jul 18 | $15.87 | $17.49 | $19.28 | -0.32% |
| Jul 19 | $15.71 | $17.48 | $19.45 | -0.38% |
| Jul 20 | $15.57 | $17.47 | $19.61 | -0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.57 | $17.47 | $19.61 | -0.44% |
| Week 2 | $14.78 | $17.39 | $20.47 | -0.89% |
| Week 3 | $14.18 | $17.32 | $21.14 | -1.33% |
| Week 4 | $13.69 | $17.24 | $21.71 | -1.77% |
| Week 5 | $13.27 | $17.16 | $22.21 | -2.20% |
| Week 6 | $12.89 | $17.09 | $22.66 | -2.64% |
| Week 7 | $12.54 | $17.01 | $23.07 | -3.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenax Therapeutics, Inc. is a healthcare company focused on developing novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.
The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
TENX is a healthcare asset trading at $17.38 per share with a current market capitalization of $461.01M and a rank of 3124.
The forecasted price path presents an ongoing, upward trajectory with multi-year average values that rise through 2050, including an average of $52.62 by 2030 and $356.29 by 2050.
A major floor 56.2% below — a decisive break under it would weaken the trend.
The nearest floor, 39.9% below — buyers have tended to step in here.
The nearest ceiling, 4.4% above — a clean break opens room to run.
A major ceiling 32.5% above — clearing it would confirm fresh momentum.
Key TENX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TENX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.45 | Buy | $17.20 | Buy |
| MA 10 | $15.75 | Buy | $16.08 | Buy |
| MA 20 | $13.91 | Buy | $14.67 | Buy |
| MA 50 | $12.64 | Buy | $13.47 | Buy |
| MA 100 | $13.19 | Buy | $12.92 | Buy |
| MA 200 | $11.66 | Buy | $11.79 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.56 | Sell |
| Stoch RSI (14) | 67.40 | Neutral |
| CCI (20) | 122.04 | Buy |
| Williams %R (14) | -12.69 | Info |
| MACD (12,26,9) | 0.54 | Buy |
| ROC (12) | 28.67 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 87.31 | Sell |
| TRIX (15) | 1.10 | Buy |
| Awesome (5,34) | 4.58 | Buy |
| Ultimate (7,14,28) | 71.89 | Sell |
| Momentum (10) | 4.66 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 18.79 | Sell |
| ADX (14) | 29.26 | Buy |
| ATR (14) | 0.64 | Info |
The near-term technical picture is bullish with RSI(14) at 70, indicating strong momentum.
The 50-day simple moving average is $12.45 and the 200-day simple moving average is $11.49, suggesting a constructive trend. Support is at $10.54 and resistance at $17.38, framing the near-term balance points.
Over the last 30 days, the price range has stretched from a low of $12.83 to a high of $23.55, underscoring notable volatility in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.54 | $17.55 | $23.16 | 0% | Neutral | |
| $17.33 | $23.04 | $32.92 | +31% | Bullish | |
| $21.74 | $30.30 | $45.72 | +73% | Bullish | |
| $27.37 | $39.72 | $62.49 | +126% | Bullish | |
| $34.72 | $52.24 | $85.10 | +198% | Bullish | |
| $34.99 | $54.43 | $91.38 | +210% | Bullish | |
| $34.19 | $54.88 | $94.64 | +213% | Bullish | |
| $38.18 | $63.14 | $111.54 | +260% | Bullish | |
| $44.36 | $75.51 | $136.36 | +330% | Bullish | |
| $58.27 | $102.00 | $187.97 | +481% | Bullish | |
| $70.69 | $141.20 | $282.98 | +705% | Bullish | |
| $162.31 | $360.68 | $814.33 | +19.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.54 | $17.55 | $21.36 | +0.00% |
| August 2026 | $14.05 | $16.85 | $20.92 | -4.00% |
| September 2026 | $13.66 | $16.56 | $20.93 | -1.71% |
| October 2026 | $14.43 | $17.68 | $22.66 | +6.74% |
| November 2026 | $14.70 | $18.15 | $23.55 | +2.67% |
| December 2026 | $14.18 | $17.65 | $23.16 | -2.75% |
Click any year to see its month-by-month TENX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TENX is projected to trade between $10.54 and $23.16, averaging $17.55 — a potential gain of 0% from today's $17.55. Price action looks broadly range-bound.
Tenax Therapeutics, Inc.'s 2027 outlook centres on $23.04, within a $17.33 to $32.92 range. That is up +31% on the projected 2026 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, TENX could reach as high as $45.72, with a base case around $30.30 and support toward $21.74 — roughly +73% from $17.55. Momentum favours further upside here.
Expect TENX to range from $27.37 to $62.49 through 2029. The $39.72 average target implies a +126% move from current prices. That is up +31% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The TENX price prediction for 2030 points to an average of $52.24 (low $34.72, high $85.10) — a potential gain of +198% on today's $17.55. Momentum favours further upside here.
In 2031, TENX is projected to trade between $34.99 and $91.38, averaging $54.43 — a potential gain of +210% from today's $17.55. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Tenax Therapeutics, Inc.'s 2032 outlook centres on $54.88, within a $34.19 to $94.64 range. That is up +1% on the projected 2031 average. That marks a +213% change versus current levels. Momentum favours further upside here.
By 2033, TENX could reach as high as $111.54, with a base case around $63.14 and support toward $38.18 — roughly +260% from $17.55. Buyers look set to stay in control over this stretch.
Expect TENX to range from $44.36 to $136.36 through 2034. The $75.51 average target implies a +330% move from current prices. That is up +20% on the projected 2033 average. Momentum favours further upside here.
The TENX price prediction for 2035 points to an average of $102.00 (low $58.27, high $187.97) — a potential gain of +481% on today's $17.55. Buyers look set to stay in control over this stretch.
In 2040, TENX is projected to trade between $70.69 and $282.98, averaging $141.20 — a potential gain of +705% from today's $17.55. That is up +38% on the projected 2035 average. Momentum favours further upside here.
Tenax Therapeutics, Inc.'s 2050 outlook centres on $360.68, within a $162.31 to $814.33 range. That is up +155% on the projected 2040 average. That marks a +19.6x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in TENX today (≈ 56.980057 TENX) could be worth
$20,551.78
+$19,551.78 (+1955%) by 2050 · US Dollar
Based on the average projected TENX price of $360.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TENXwould be worth at today's price.
$1,000 invested in TENX on Jul 10, 2025 (≈ 173.190158 TENX) would be worth
$3,039.49
+$2,039.49 (+203.9%) today · 3.04× · US Dollar
Based on a TENX entry price of $5.77 vs. today's $17.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.46 | $1,135.19 | +13.5% |
| 1 month ago | $10.55 | $1,663.51 | +66.4% |
| 3 months ago | $14.43 | $1,216.64 | +21.7% |
| 6 months ago | $14.7 | $1,193.88 | +19.4% |
| 1 year ago | $5.77 | $3,039.49 | +203.9% |
| All time (5.0y) ago | $3,072 | $5.71 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TENX forecast.
Our base-case forecast reaches $35.00 around 2029.
Implied market cap at $35.00: $928.38M
The multi-year forecast shows rising activity in the Avg column across years, starting at $17.38 in 2026 and climbing to $22.77 (2027), $29.58 (2028), $39.23 (2029), and $52.62 (2030), with a 2026 ROI of 0 and a bullish sentiment.
From 2031 onward, Avg values continue to rise to $53.72 (2031), $53.65 (2032) and $62.89 (2033), then $73.37 (2034) and $100.04 (2035), with growing confidence and sustained bullish sentiment. By 2040, Avg is $136.17 and by 2050, Avg is $356.29, accompanied by substantial ROI figures (e.g., 202.7% in 2030, 209.1% in 2031, 208.7% in 2032, 261.8% in 2033, 322.1% in 2034, 475.6% in 2035, 683.5% in 2040, and 1950% in 2050). These figures reflect a long-run bullish outlook, acknowledging that these are estimates and not guarantees.
Risks include market and sector volatility and the inherent uncertainty of long-horizon forecasts; actual results may differ from these projections.
Tap a question to reveal the answer.
Avg $52.62, min $34.33, max $87.19; ROI 202.7; sentiment BULLISH.
The forecast shows a bullish trajectory with rising Avg values through 2030–2050 and notable max values, but these are estimates and not guarantees. Current indicators show bullish technical sentiment and a forward-looking path of growth.
Yes. The forecast projects Max values of $188.35 by 2035 and $279.61 by 2040, with $819.46 as the max by 2050.
Avg $17.38, min $10.54, max $22.94; ROI 0; sentiment NEUTRAL.
Tenax Therapeutics, Inc. Community Discussion
0Share your Tenax Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.